GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AVDL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Avadel Pharmaceuticals plc stock after losing 0.288%
(Updated on Apr 19, 2024)

Buy or Hold candidate since Mar 04, 2024 Gain 7.44% PDF

The Avadel Pharmaceuticals plc stock price fell by -0.288% on the last day (Friday, 19th Apr 2024) from $17.38 to $17.33. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.96% from a day low at $17.18 to a day high of $17.86. The price has fallen in 6 of the last 10 days but is still up by 3.83% over the past 2 weeks. Volume has increased on the last day by 225 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $23.04 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 26.28% during the next 3 months and, with a 90% probability hold a price between $18.64 and $23.08 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AVDL Signals & Forecast

The Avadel Pharmaceuticals plc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $17.11 and $16.45. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 16, 2024, and so far it has fallen -4.20%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Avadel Pharmaceuticals plc stock

Avadel Pharmaceuticals plc finds support from accumulated volume at $17.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.680 between high and low, or 3.96%. For the last week, the stock has had daily average volatility of 9.06%.

Our recommended stop-loss: $16.58 (-4.31%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (AVDL) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Avadel Pharmaceuticals plc to open at $17.46, and during the day (based on 14 day Average True Range), to move between $16.36 and $18.30, which gives a possible trading interval of +/-$0.97 (+/-5.57%) up or down from last closing price. If Avadel Pharmaceuticals plc takes out the full calculated possible swing range there will be an estimated 11.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $17.38 (0.29%) than the support at $17.00 (1.90%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Avadel Pharmaceuticals plc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Avadel Pharmaceuticals plc stock to perform well in the short-term.

Current score: 3.366 Buy Candidate Unchanged

Predicted Opening Price for Avadel Pharmaceuticals plc of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$17.46 ( 0.731%) $17.33

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AVDL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 18.14 4.65 %
R2 17.88 3.16 %
R1 17.72 2.23 %
Current price: 17.33
Support S1 17.20 -0.768 %
S2 17.04 -1.69 %
S3 16.78 -3.19 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 18.09 4.39 %
R2 17.99 3.81 %
R1 17.38 0.289 %
Current price 17.33
Support S1 17.00 -1.90%
S2 16.13 -6.92%
S3 13.72 -20.83%

FAQ

What is the symbol for Avadel Pharmaceuticals plc Stock and on which exchange is it traded?
The symbol for Avadel Pharmaceuticals plc is AVDL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Avadel Pharmaceuticals plc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Avadel Pharmaceuticals plc stock to perform well in the short-term.

How to buy Avadel Pharmaceuticals plc Stock?
Avadel Pharmaceuticals plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Avadel Pharmaceuticals plc Stock.

What's the current price of Avadel Pharmaceuticals plc Stock?
As of the end of day on the 2024-04-19, the price of an Avadel Pharmaceuticals plc (AVDL) share was $17.33.

What is the 52-week high and low for Avadel Pharmaceuticals plc Stock?
The 52-week high for Avadel Pharmaceuticals plc Stock is $18.85 and the 52-week low is $9.50.

What is the market capitalization of Avadel Pharmaceuticals plc Stock?
As of the 2024-04-19, the market capitalization of Avadel Pharmaceuticals plc is 1.629B.

When is the next earnings date for Avadel Pharmaceuticals plc?
The upcoming earnings date for Avadel Pharmaceuticals plc is May 02, 2024.
Click to get the best stock tips daily for free!

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorpo... AVDL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT